Diffuse hair loss: which causes and tests should be considered?

What does hair loss spread across the scalp mean?

Thinning may make a parting more noticeable, reduce the volume of a hairstyle or reveal more skin between the hairs. “Diffuse” does not necessarily mean that every region is affected to the same degree. A doctor compares several areas to establish the distribution, including those that still appear well covered.

They also distinguish hairs that are falling out from those becoming finer. Heavy shedding can occur while coverage remains relatively good; finer hairs can reduce volume without a striking accumulation on the brush. Broken shafts are another possibility, which examining their length and condition helps identify.

This description alone cannot predict either complete baldness or full regrowth. Nor does it refer to a condition exclusive to women: men can also experience widespread loss. Our overview of the different forms of alopecia places these changes alongside other types of hair loss.

Which causes can look similar or occur together?

In telogen effluvium, more hairs leave their growing phase and move towards rest before being shed. A feverish illness, childbirth, an operation, substantial dietary restriction or certain medication changes may precede the episode. There is often a delay of a few months, so the doctor asks about events before the shedding became apparent. Our article on telogen effluvium explains its course in more detail.

Androgenetic alopecia can also cause widespread thinning. In women, reduced coverage often predominates over the top of the scalp; in men, some presentations are more diffuse than a receding hairline alone. Affected follicles gradually produce finer hairs. Our article on androgenetic alopecia explains the features of this miniaturisation.

These two mechanisms can coexist. An episode of shedding may reveal previously unnoticed miniaturisation, then settle without all the former density returning. Werner and Mulinari-Brenner’s review highlights this diagnostic difficulty: attributing every change to the most recent stressful event may leave another cause undetected.

Diffuse alopecia areata is another possibility. This immune-mediated condition does not always produce the clearly defined patches usually associated with it. It can resemble telogen effluvium, sometimes making a specialist examination necessary. The history and findings under magnification help guide the diagnosis; our article on alopecia areata describes its other manifestations.

Damage to actively growing hairs, known as anagen effluvium, can occur with some chemotherapy treatments. Thyroid disorders, iron deficiency and systemic illness are also considered according to the clinical history. These possibilities explain why two people with apparently similar thinning may need different approaches to care.

When should you book an appointment, and which signs matter?

A persistent reduction in volume, unusual shedding or ongoing worry is sufficient reason to speak to your GP. The number of hairs you notice depends partly on washing and styling habits, limiting the usefulness of a daily threshold on its own. Counting every hair cannot replace an assessment of changes in coverage and how long they have been present.

Describe rapid progression, emerging patches, eyebrow loss or nail changes to the doctor. Also mention unusual tiredness, weight changes or heavy periods, which can help direct investigations. These signs do not establish a particular cause, but their combination provides useful information.

Painful, red or scaly skin, or smooth areas that look scarred, warrant prompt assessment rather than waiting to see whether hair returns. Some inflammatory conditions can permanently damage follicles. Our article on scarring alopecia explains why recognising these conditions early matters, even when some of the loss looks diffuse.

How does a doctor distinguish the different mechanisms?

The consultation establishes a timeline: the first change you noticed, any acceleration, earlier episodes and events in the preceding months. A list of medicines, supplements and hair products helps identify possible links. Family history adds context without determining the diagnosis by itself.

The examination covers the whole scalp, comparing the front, crown, sides and back. The clinician looks at hair calibre, length, possible breakage and the condition of the skin. Examining only the parting or the thinnest area could miss more extensive involvement or a useful difference between regions.

Trichoscopy allows the hair and scalp to be examined under magnification. Differences in shaft diameter, broken hairs or signs around follicular openings can help distinguish the underlying processes. A hair pull test, when performed, assesses how readily hairs come away; a positive result does not automatically identify telogen effluvium.

A biopsy may be offered when examination and trichoscopy leave the diagnosis uncertain, or an inflammatory condition is suspected. This involves removing a small sample of scalp skin for analysis. It is not a routine requirement: the dermatologist decides whether it is needed and where to sample according to the remaining diagnostic question.

Which blood tests can be useful?

Blood tests address possibilities raised during the consultation. A full blood count and ferritin measurement can investigate anaemia or iron deficiency, while a TSH test can assess thyroid function. These tests may be considered when shedding remains unexplained, persists or accompanies other suggestive findings.

Ferritin needs to be interpreted in context. It reflects iron stores but may also rise during inflammation, and publications do not all use the same threshold in relation to hair loss. A single result therefore cannot establish a universal “ideal level for hair” or predict the response to supplementation.

Additional vitamin, zinc or hormone tests depend on the circumstances, such as a highly restrictive diet, an absorption problem or signs of excess androgens. New unwanted facial or body hair, or disrupted menstrual cycles, may prompt an appropriate investigation. Ordering a comprehensive panel without a specific clinical question can produce results that are difficult to interpret.

Mention supplements before a blood test, even if you bought them without a prescription. Biotin in some oral hair supplements can interfere with laboratory tests, including thyroid tests; the laboratory or prescriber will explain any necessary precautions. Normal blood results are also compatible with several hair disorders: testing supports the examination rather than replacing it.

How is an appropriate treatment chosen?

When a correctable factor is identified, care first addresses that factor. A confirmed deficiency, a thyroid disorder and an inadequate diet each require a specific response. If a medicine is suspected, the prescriber considers the timing, its purpose and possible alternatives; stopping treatment yourself may create another health problem.

Supplements are not a treatment shared by all forms of diffuse loss. Almohanna and colleagues’ review reports mixed findings and insufficient evidence for many supplements. Excessive amounts of some nutrients, particularly vitamin A or selenium, can themselves contribute to shedding. Correcting a documented deficiency is therefore different from combining multiple products marketed for hair growth.

When androgenetic alopecia is diagnosed, a treatment such as topical minoxidil may be discussed according to individual suitability and precautions. Responses vary, and maintaining a benefit generally requires continued use. Alopecia areata or scalp inflammation needs a different strategy: choosing a product simply because the loss looks diffuse may delay appropriate care.

Comfort and appearance can also form part of care. A hairstyle that puts less tension on the hair, or a hairpiece, may help during a period of reduced density, according to personal preferences. If hair loss affects relationships, work or mood, discussing this allows support to become part of treatment without dismissing the hair concern itself.

How can recovery be monitored?

Reduced shedding, new growth and restored volume do not necessarily happen at the same time. With telogen effluvium, the delay between the trigger and the first lost hairs must be distinguished from the duration of shedding and the time needed for noticeable length to return. Hairs already committed to their cycle may continue falling after the original trigger has resolved.

Changes commonly unfold over several months, but the word “diffuse” cannot provide a recovery date. Prolonged shedding may reflect persistent factors, repeated episodes or another condition occurring alongside it. Removing the trigger alone does not ensure that previous density will return exactly.

A few comparable photographs, taken with similar parting, lighting and styling, can help with follow-up. They provide a basis for discussing progress with the doctor, but do not measure follicle activity on their own. Worsening loss, new symptoms or progress that differs from expectations should prompt a reassessment of the diagnosis and care plan.

When should a transplant be ruled out or postponed?

Active or unexplained diffuse loss needs assessment first. Transplantation moves follicles; it does not correct a disturbed hair cycle or treat a systemic illness. Our hair transplant guide describes the surgical stages, which become relevant only once suitability has been established.

The quality of the donor area is decisive. If miniaturisation and thinning also affect the sides and back of the head, the surgeon must establish whether a sufficiently preserved region remains. This situation is described in diffuse unpatterned alopecia, or DUPA. True’s review advises against transplantation when there is no reliable donor area; simply counting available grafts does not resolve that problem.

Conversely, some forms of widespread thinning over the top of the head leave a usable reserve. Surgery may then be considered according to the diagnosis, progression and coverage that can reasonably be achieved. Risks include scarring and a worsening of the sparse appearance; no choice of instrument ensures a particular result.

When contacting Body Expert about a hair transplant in Istanbul, explain what your assessment has established and what remains uncertain. A proposal may be postponed, limited or ruled out following examination. This decision helps protect the donor reserve while appropriate care for the cause of the loss continues.

Sources

Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2019). The role of vitamins and minerals in hair loss: A review. Dermatology and Therapy, 9(1), 51-70. https://doi.org/10.1007/s13555-018-0278-6

Malkud, S. (2015). Telogen effluvium: A review. Journal of Clinical and Diagnostic Research, 9(9), WE01-WE03. https://doi.org/10.7860/JCDR/2015/15219.6492

National Health Service. (2024, January 24). Hair loss. https://www.nhs.uk/symptoms/hair-loss/

Qi, J., & Garza, L. A. (2014). An overview of alopecias. Cold Spring Harbor Perspectives in Medicine, 4(3), a013615. https://doi.org/10.1101/cshperspect.a013615

True, R. H. (2021). Is every patient of hair loss a candidate for hair transplant? Deciding surgical candidacy in pattern hair loss. Indian Journal of Plastic Surgery, 54(4), 435-440. https://doi.org/10.1055/s-0041-1739247

Werner, B., & Mulinari-Brenner, F. (2012). Clinical and histological challenge in the differential diagnosis of diffuse alopecia: Female androgenetic alopecia, telogen effluvium and alopecia areata, Part II. Anais Brasileiros de Dermatologia, 87(6), 884-890. https://doi.org/10.1590/S0365-05962012000600010